Richter is a top pick for local fund managers, though.
Hires BofA-ML to run the sale, Reuters reports.
One of key products under EMA investigation.
Vojvodjanska banka integration to be complete in Q2 2019.
Flagship product Emsya under the microscope. Richter reacts.
The rating view comes from China.
And still remains well behind actual share price.
Listing can come afterwards.
Outlook is Stable.
And also settles existing agreement.
After robust Q3 figures.
January-September profit exceeds annual profit of 2016.
Management expect strong competition.
Profit greatly beats expectations.
Regardless of rouble trouble.
Pharma firm buys treasury shares again for HUF 370 mn.
A report from the Portfolio Energy Investment Forum 2017 conference.
Share price approaches multi-year high.
Performance in quarterly terms not so stellar, though.